Two Distinct Transcriptional Subtypes of Severe Type 2 Asthma in NSAID ‐Exacerbated Respiratory Disease

Documenti analoghi

• Sputum Eosinophil and Macrophage Changes After Aspirin Challenge in Patients With Nonsteroidal Anti‐Inflammatory Drug–Exacerbated Respiratory Disease
  di: Gabriela Trąd‐Wójcik, et al.
  Pubblicazione: (2025)
• Unique effect of aspirin on local 15‐oxo‐eicosatetraenoic acid synthesis in asthma patients with aspirin hypersensitivity
  di: Piotr Szatkowski, et al.
  Pubblicazione: (2024)
• Effect of Aspirin Challenge on Innate Lymphoid Cells in Asthma Patients With Aspirin Hypersensitivity
  di: Radosław Kacorzyk, et al.
  Pubblicazione: (2025)
• Omics in Nonsteroidal Anti‐Inflammatory Drugs‐Exacerbated Respiratory Disease: Current Evidence From the Upper and Lower Airways
  di: Aleksandr iAkushev, et al.
  Pubblicazione: (2025)
• Systemic N‐Acylethanolamines and Other Lipid Mediators Are Associated With NSAID ‐Exacerbated Respiratory Disease
  di: Viljami E. Salmi, et al.
  Pubblicazione: (2025)